Benjamin Micheal Patrick Clasie, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiotherapy Planning, Computer-Assisted | 17 | 2024 | 1680 | 1.950 |
Why?
|
| Radiometry | 10 | 2024 | 817 | 1.390 |
Why?
|
| Protons | 6 | 2022 | 1112 | 1.380 |
Why?
|
| Monte Carlo Method | 7 | 2024 | 1261 | 1.190 |
Why?
|
| Radiotherapy Dosage | 19 | 2024 | 2922 | 0.980 |
Why?
|
| Radiation Dosage | 4 | 2018 | 1974 | 0.440 |
Why?
|
| Phantoms, Imaging | 5 | 2024 | 2528 | 0.340 |
Why?
|
| Algorithms | 8 | 2022 | 14154 | 0.330 |
Why?
|
| Quality Assurance, Health Care | 1 | 2018 | 2181 | 0.290 |
Why?
|
| Calibration | 2 | 2022 | 823 | 0.250 |
Why?
|
| Radiotherapy, Intensity-Modulated | 3 | 2020 | 812 | 0.240 |
Why?
|
| Linear Energy Transfer | 2 | 2024 | 154 | 0.230 |
Why?
|
| Facility Design and Construction | 1 | 2023 | 85 | 0.210 |
Why?
|
| Equipment Design | 2 | 2023 | 3529 | 0.210 |
Why?
|
| Ependymoma | 1 | 2024 | 328 | 0.180 |
Why?
|
| Models, Theoretical | 1 | 2012 | 3579 | 0.180 |
Why?
|
| Microtechnology | 1 | 2017 | 70 | 0.140 |
Why?
|
| Scattering, Radiation | 3 | 2017 | 489 | 0.140 |
Why?
|
| Technology, Radiologic | 2 | 2014 | 160 | 0.130 |
Why?
|
| Models, Biological | 2 | 2010 | 9493 | 0.130 |
Why?
|
| Germany | 1 | 2018 | 882 | 0.130 |
Why?
|
| Relative Biological Effectiveness | 3 | 2012 | 313 | 0.120 |
Why?
|
| Normal Distribution | 1 | 2012 | 272 | 0.090 |
Why?
|
| Ions | 1 | 2012 | 256 | 0.090 |
Why?
|
| Radiation, Ionizing | 1 | 2012 | 252 | 0.090 |
Why?
|
| Calorimetry | 1 | 2010 | 132 | 0.090 |
Why?
|
| Liposarcoma, Myxoid | 1 | 2010 | 60 | 0.080 |
Why?
|
| Neutrons | 1 | 2009 | 78 | 0.080 |
Why?
|
| Organs at Risk | 2 | 2024 | 368 | 0.080 |
Why?
|
| Radiotherapy, Conformal | 2 | 2010 | 549 | 0.080 |
Why?
|
| Humans | 22 | 2024 | 768393 | 0.070 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2010 | 335 | 0.070 |
Why?
|
| Carbon | 1 | 2010 | 672 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 1 | 2019 | 2923 | 0.060 |
Why?
|
| Photons | 1 | 2008 | 595 | 0.060 |
Why?
|
| Water | 1 | 2010 | 1418 | 0.060 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2008 | 876 | 0.050 |
Why?
|
| Silicon | 1 | 2024 | 143 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2024 | 9198 | 0.050 |
Why?
|
| Radiation Oncology | 1 | 2008 | 573 | 0.050 |
Why?
|
| Physical Phenomena | 1 | 2020 | 48 | 0.040 |
Why?
|
| Uncertainty | 2 | 2019 | 759 | 0.040 |
Why?
|
| Computer Simulation | 2 | 2010 | 6277 | 0.040 |
Why?
|
| Scintillation Counting | 1 | 2019 | 36 | 0.040 |
Why?
|
| Prostatic Neoplasms | 2 | 2019 | 11221 | 0.040 |
Why?
|
| Brain Stem | 1 | 2024 | 862 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2012 | 5099 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 20224 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20765 | 0.030 |
Why?
|
| Neoplasms | 3 | 2010 | 22385 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2019 | 1998 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 13576 | 0.030 |
Why?
|
| Thermal Conductivity | 1 | 2010 | 16 | 0.020 |
Why?
|
| Fast Neutrons | 1 | 2010 | 18 | 0.020 |
Why?
|
| International Agencies | 1 | 2009 | 245 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2008 | 881 | 0.020 |
Why?
|
| Radiation Protection | 1 | 2009 | 428 | 0.020 |
Why?
|
| Cell Communication | 1 | 2012 | 1660 | 0.020 |
Why?
|
| Radiography | 1 | 2014 | 6993 | 0.010 |
Why?
|
| Cell Survival | 1 | 2012 | 5792 | 0.010 |
Why?
|
| Radiation Injuries | 1 | 2008 | 1204 | 0.010 |
Why?
|
| Male | 4 | 2020 | 364902 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 17135 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 40272 | 0.000 |
Why?
|
| Middle Aged | 1 | 2010 | 223491 | 0.000 |
Why?
|